Bionor Immuno AS
Biomedical drug development company
Export Market
Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
Additional Information
Finance
Total revenues:
40
Operating profit:-11.348
Operating profit before tax:
-12.097
Total assets: 901
Total equity:-824
Currency: NOK (all numbers in thousands)
Management
Board Chairman:
Birger Sørensen
Board Members:
Birger Sørensen
Dag Arne Wivelstad
General Manager:
Birger Sørensen
Subsidiary companies:
Largest shareholders:
N/A
KEYWORDS
Biobank, Biomedical equipment, Biotechnology, Health Care, Medical analysis services, Pharmacological Treatments (New Medicines & Therapies), Terapeutica, Therapeutic agents, Vaccines,